España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Bayer
BAYZF
OTCPK
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$22.44
At close: May 31, 8:52 AM EDT
$30.72
8.28
36.90%
After Hours: May 31, 8:52 AM EDT
Get Report
Comment
Bayer (BAYZF) Forecast
News
Earnings
Bayer (BAYZF) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Bayer (OTC:BAYZF) Stock
Bayer Stock (OTC: BAYZF)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, November 12, 2024
Bayer Confirms Its 2024 Guidance, Sales Of €4...
Benzinga Newsdesk
Thursday, July 25, 2024
Bayer Weedkiller Lawsuit Dismissed By Australian Judge: Insufficient Evidence Linking Roundup To Blood Cancer
Vandana Singh
Wednesday, June 05, 2024
Judge Slashes Bayer's Massive $2B Roundup Verdict To $400M
Vandana Singh
Friday, May 24, 2024
After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stolen In Data Breach In February
Vandana Singh
Friday, May 17, 2024
Bayer Highlights Detailed Data From Twin Late-Stage Trials On Experimental Menopause Candidate, Seeks Regulatory Approval
Vandana Singh
Thursday, May 02, 2024
Bayer's Monsanto Scores Legal Victory as $185M Verdict Overturned
Vandana Singh
Tuesday, March 19, 2024
Bayer's Third Menopausal Relief Drug Trial Meets Primary Goal, German Conglomerate Seeks FDA Approval For Elinzanetant
Vandana Singh
Thursday, March 14, 2024
German Conglomerate Bayer Goes Johnson & Johnson Way To Tackle Its Cancer Related Lawsuits
Vandana Singh
Wednesday, March 06, 2024
Boundless Bio Files For IPO; Applies To List ...
Benzinga Newsdesk
Tuesday, March 05, 2024
Bayer Holds Splitting Into Separate Units For Three Years, Focus Shifts On Tackling Challenges
Vandana Singh
Monday, March 04, 2024
What's Going On With BridgeBio Pharma Stock On Monday?
Vandana Singh
Tuesday, January 30, 2024
Weedkiller Woes: Australian Court Nears Decision in Bayer's Roundup Trial
Vandana Singh
Monday, January 29, 2024
Roundup Cancer Verdict: Woes Continue For Bayer As It Faces $2.2B Payout
Vandana Singh
Thursday, January 11, 2024
Large Drugmakers Show Enthusiasm To Embrace $100B Obesity Market, Despite Novo And Lilly's Dominance
Vandana Singh
Monday, January 08, 2024
Menopause Management: Bayer's Non-Hormonal Treatment Option Shows Efficacy In Trial
Vandana Singh
Thursday, January 04, 2024
Bayer Study On Parkinson's Disease Gene Therapy Succeeds In Early-Stage Trial
Vandana Singh
Tuesday, December 26, 2023
Legal Victory For Bayer: Roundup Lawsuit Ends Five-Trial Losing Streak
Vandana Singh
Tuesday, December 19, 2023
ESG Stocks Take Center Stage As Damages From Climate-Related Events Rise Exponentially Within US
Surbhi Jain
Wednesday, December 06, 2023
Bayer Faces $3.5M Verdict in Fifth Consecutive Roundup Weedkiller Loss
Vandana Singh
Monday, December 04, 2023
Bayer Faces Growing Pressure Amid Roundup Lawsuits as Philadelphia Trial Nears Conclusion
Vandana Singh
Friday, November 24, 2023
German Conglomerate Bayer Faces Investor Scrutiny Amid Unexpected Legal, Trial Setbacks
Vandana Singh
Monday, November 20, 2023
Analyst Assess Implications of Bristol Myers' Investigational Blood Thinner Post Bayer Trial Setback Amid Shaken Investor Confidence
Vandana Singh
Bayer's Blood Thinner Study Stopped Early Due To Lack Of Efficacy: Details
Vandana Singh
Friday, November 17, 2023
Bayer's Legal Victory Against Merck: Delaware Court Rules In Company's Favor Regarding Talc Lawsuits
Vandana Singh
Wednesday, November 08, 2023
Bayer CEO Resists Full Tri-Split, German Conglomerate Cuts Management Jobs In The Face Of Q3 Loss
Vandana Singh
Wednesday, November 01, 2023
Legal Woes Mount for Bayer As Roundup Weed Killer-Related Cancer Cases Continue, Faces Third Trial Loss
Vandana Singh
Friday, September 22, 2023
From Years to Months: How AI is Shaping the Landscape of Clinical Trials
Vandana Singh
Monday, August 28, 2023
Hawaiian Electric Says Power Lines Not Responsible For Deadly Lahaina Fire, China Targets Stock Market Revival, FTC Pauses Legal Battle With Amgen's $28B Horizon Deal: Today's Top Stories
Vandana Singh
German Pharma Firm Bayer's New Parkinson's Treatment Shows Promise: What the Phase 1 Trial Reveals
Vandana Singh
Monday, August 21, 2023
FDA Approves Regeneron Pharmaceuticals' Higher Dose Of Eylea For Age-Related Blindness
Vandana Singh
Tuesday, August 08, 2023
Bayer Lowered Its FY23 Outlook, Now Sees Sale...
Benzinga Newsdesk
Bayer Q2 EPS $0.33 Beats $0.31 Estimate, Sale...
Benzinga Newsdesk
Thursday, June 29, 2023
AstraZeneca's Imfinzi/Imjudo Combo Shows Sustained Overall Survival Benefit At Four Years In Liver Cancer
Vandana Singh
Wednesday, June 28, 2023
Bayers Says Neuronal Stem Cell Therapy For Parkinson's Shows Encouraging Action In Early-Stage Study
Vandana Singh
Tuesday, April 04, 2023
US Court Favors Bayer In Lawsuit Against Merck On Talc Liabilities
Vandana Singh
Friday, March 10, 2023
Bayer Seeks To Double US Revenues Over Next Decade, With Planned R&D Spending Of Around $1B
Vandana Singh
Wednesday, January 18, 2023
Bayer Bolsters Its Position In Digital Medical Imaging With Acquisition Of UK-Based Firm
Vandana Singh
Wednesday, January 11, 2023
FAA Technology Glitch Hits US Flights Operations, Coca-Cola & PepsiCo Under FTC Probe, Rivian's Executive Departures: Today's Top Stories
Vandana Singh
Activist Investor Builds Stake In Bayer, Pushes Breakup
Vandana Singh
Friday, November 04, 2022
Ionis Regains Rights To Thrombosis Candidate From Bayer
Vandana Singh
Wednesday, October 05, 2022
Roundup Weedkiller Maker Bayer Won Five Consecutive Cases, Shifting Momentum In Bayer's Favor
Vandana Singh
Wednesday, September 14, 2022
After Investor Flak, German Healthcare Giant Bayer Starts Hunt For New CEO: Report
Vandana Singh
Thursday, September 08, 2022
Regeneron Gains As New Data Favors Higher Dose Of Flagship Eye Disease Drug
Vandana Singh
Monday, August 29, 2022
Bayer's Kidney Disease Drug Disappoints On Cutting Cardiovascular Death
Vandana Singh
Monday, August 08, 2022
FDA Approves Expanded Use For Bayer's Prostate Cancer Drug
Vandana Singh
Friday, June 10, 2022
Morning Brief: Top Financial Stories Dominating on Friday, June 10
Akanksha Bakshi
US Top Court To Decide On Bayer's Roundup Weedkiller Appeal
Anusuya Lahiri
Friday, May 20, 2022
Bayer Intends To Bow Out From CAR-T Therapy Pact With Atara
Vandana Singh
Thursday, April 21, 2022
FDA Puts Blood Cancer Nods Under Scrutiny On Substantial Toxicity Profile Of PI3K Drugs
Vandana Singh
Tuesday, March 15, 2022
Eli Lilly To Suspend Sale Of 'Non-Essential' Medicines To Russia
Vandana Singh
Show More
